Found: 8
Select item for more details and to access through your institution.
Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.
- Published in:
- Journal of NeuroVirology, 2019, v. 25, n. 6, p. 866, doi. 10.1007/s13365-019-00780-9
- By:
- Publication type:
- Article
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical and molecular characterization of COVID-19 hospitalized patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0242534
- By:
- Publication type:
- Article
'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice.
- Published in:
- HIV Medicine, 2020, v. 21, n. 2, p. e1, doi. 10.1111/hiv.12783
- By:
- Publication type:
- Article
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2019, v. 101, n. 3, p. 494, doi. 10.4269/ajtmh.19-0262
- By:
- Publication type:
- Article
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 1, p. 14, doi. 10.3390/diagnostics12010014
- By:
- Publication type:
- Article
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.
- Published in:
- Infezioni in Medicina, 2018, v. 26, n. 4, p. 336
- By:
- Publication type:
- Article
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter